We detected CPQ-PRKDC fusion transcripts in three (2.5%) of the 122 primary tumor tissues; whereas we failed to detect VGLL4-PRKG1 or CAPZA2-MET fusion transcripts in any of the clinical samples (Table 1). This evidence concerns the gene VGLL4 and neoplasm.